Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Mercer

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Obstetrics and Gynecology|June 24, 2009
Bone metabolism in fetuses of pregnant women exposed to single and multiple courses of corticosteroidsLinda Fonseca, Susan M Ramin, Lisa Mele, et al.
Obstetrics and Gynecology|June 3, 2008
Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroidsMary A Carroll, Alex C Vidaeff, Lisa Mele, et al.
American Journal of Obstetrics and Gynecology|July 19, 2006
Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacyRonald J Wapner, Yoram Sorokin, Elizabeth A Thom, et al.
American Journal of Perinatology|August 6, 2021
Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health StudyLauren H Theilen, Rebecca B McNeil, Shannon Hunter, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 10, 2010
Absence of mitochondrial progesterone receptor polymorphisms in women with spontaneous preterm birthTracy A Manuck, Thomas M Price, Elizabeth Thom, et al.
Obstetrics and Gynecology|September 2, 2005
Does progesterone treatment influence risk factors for recurrent preterm delivery?Paul J Meis, Mark Klebanoff, Mitchell P Dombrowski, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm deliveryBaha Sibai, Paul J Meis, Mark Klebanoff, et al.
The New England Journal of Medicine|June 13, 2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproatePaul J Meis, Mark Klebanoff, Elizabeth Thom, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous deliveryCatherine Y Spong, Paul J Meis, Elizabeth A Thom, et al.
JAMA Cardiology|April 2, 2025
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery: The nuMoM2b Heart Health StudyPriya M Freaney, Xiaoning Huang, Lucia C Petito, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Obstetrics and Gynecology|June 24, 2009
Bone metabolism in fetuses of pregnant women exposed to single and multiple courses of corticosteroidsLinda Fonseca, Susan M Ramin, Lisa Mele, et al.
Obstetrics and Gynecology|June 3, 2008
Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroidsMary A Carroll, Alex C Vidaeff, Lisa Mele, et al.
American Journal of Obstetrics and Gynecology|July 19, 2006
Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacyRonald J Wapner, Yoram Sorokin, Elizabeth A Thom, et al.
American Journal of Perinatology|August 6, 2021
Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health StudyLauren H Theilen, Rebecca B McNeil, Shannon Hunter, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 10, 2010
Absence of mitochondrial progesterone receptor polymorphisms in women with spontaneous preterm birthTracy A Manuck, Thomas M Price, Elizabeth Thom, et al.
Obstetrics and Gynecology|September 2, 2005
Does progesterone treatment influence risk factors for recurrent preterm delivery?Paul J Meis, Mark Klebanoff, Mitchell P Dombrowski, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm deliveryBaha Sibai, Paul J Meis, Mark Klebanoff, et al.
The New England Journal of Medicine|June 13, 2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproatePaul J Meis, Mark Klebanoff, Elizabeth Thom, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous deliveryCatherine Y Spong, Paul J Meis, Elizabeth A Thom, et al.
JAMA Cardiology|April 2, 2025
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery: The nuMoM2b Heart Health StudyPriya M Freaney, Xiaoning Huang, Lucia C Petito, et al.
Pageof 7